Treatment with Tumor Necrosis Factor-α and Granulocyte–Macrophage Colony-Stimulating Factor Increases Epidermal Langerhans' Cell Numbers in Cancer Patients

This publication has 37 references indexed in Scilit:

• Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.
  The Journal of Experimental Medicine, 1996
• Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
  The Journal of Experimental Medicine, 1996
• Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity.
  The Journal of Experimental Medicine, 1996
• Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40‐ligand) and TNF‐α, but strongly enhanced by interleukin‐10
  European Journal of Immunology, 1995
• SYSTEMIC LIPOPOLYSACCHARIDE RECRUITS DENDRITIC CELL PROGENITORS TO NONLYMPHOID TISSUES
  Transplantation, 1995
• Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?
  Immunology Today, 1995
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
  Nature, 1992
• Anti-melanoma monoclonal antibody HMB45 identifies an oncofetal glycoconjugate associated with immature melanosomes.
  Journal of Histochemistry & Cytochemistry, 1992
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991